Gujarat Kidney IPO Final Day: Issue sees 5.21x subscription amid strong retail demand-Check for key details

Gujarat Kidney IPO: The initial public offering (IPO) of Gujarat Kidney and Super Speciality Ltd concluded its final day of public bidding on Wednesday, December 24, with the issue subscribed 5.21 times, as per the provisional exchange data. The public offer consists of an entirely fresh issue of shares, with no offer-for-sale (OFS) component.

Gujarat Kidney IPO subscription status

At the end of the bidding window, investors bid for 6.89 crore shares against the total shares on offer. The subscription includes bids from institutional buyers, investors and retailers, who subscribed 1.06, 5.73 and 19.04 times against their allotted portion.

Add Zee Business as a Preferred Source

In terms of shares, the QIB, NII and RII quotas overall booked 81.88 lakh, 1.88 crore and 4.18 crore shares against their reserved categories.

Gujarat Kidney IPO details

The Gujarat Kidney IPO is a book-building issue of around Rs 251 crore, comprising an entirely fresh issue of 2.20 shares.

The IPO has reserved 75 per cent, 15 per cent and 10 per cent of the net offer for the QIB, NII and retail investor categories, respectively.

The minimum amount of investment required by a retail investor is Rs 14,592, indicating a lot size of 128 shares (based on the upper end of the price band).

Price band: Rs 108 to Rs 114 per equity share

Subscription date: December 22 to December 24, 2025

Allotment date: December 26, 2025

Listing date: December 30, 2025

About Gujarat Kidney and Super Speciality Limited

Gujarat Kidney and Super Speciality operates seven mid-sized multi-speciality hospitals across Gujarat, with a total capacity of 490 beds. The company focuses on secondary and tertiary care services.

For FY25, the company reported revenue of Rs 40.24 crore and a net profit of Rs 9.5 crore, highlighting steady financial performance.